The team of scientists led by Dr. Michael Lammers at CECAD, the Cluster of Excellence at the University of Cologne, has discovered that the essential cellular protein Ran is fundamentally regulated by lysine acetylation. Ran belongs to the family of Ras proteins, which regulate fundamental cellular processes such as cell differentiation, cell division, and intracellular transport. Mutations in Ras-related proteins are involved in the development of various types of cancer including colorectal cancer, lung cancer, and lymphomas. Mechanisms that can switch off the functions of Ran protein are therefore of particular therapeutic interest.
Discoveries made by scientists in Cologne lead to new perspectives in the treatment of colorectal cancer, lung cancer, and lymphomas. Dr. Michael Lammers and his research team at CECAD have identified new regulatory mechanisms for Ran protein.
They have shown that all essential functions of the small GTP-binding Ran protein can be regulated by lysine acetylation. Ran is involved in many important cell processes including cell division and protein transport. Dysregulation of these processes has dramatic effects on normal cell development.
Many types of tumor cells have increased concentrations of Ran or Ran-interacting proteins or Ran-regulators. Switching off Ran-function in a targeted manner, using the newly identified regulatory system, may provide novel therapeutic approaches.
The small Ran protein is a molecular switch that can be turned on or off depending on the nucleotide charge. If this switch protein is not regulated properly, there may be far-reaching effects on essential cell functions.
Using high-resolution quantitative mass spectrometry, it has recently been shown that many of many of the amino acids – the lysines – in the Ran protein can be modified by adding an acetyl group. Modifications of this type made to the folded protein, once biosynthesis is complete, essentially alter and regulate protein function. Some of the acetylation sites are to be found in highly relevant functional regions within the Ran protein.
Dr. Lammers: “With a combined synthetic biological, biochemical, and cell biological approach, we have shown that lysine acetylation regulates nearly all essential Ran functions – something that was completely unknown beforehand. For some of the sites, we have also been successful in identifying specific enzymes responsible to modify the protein in this way, adding and removing such modifications. These findings may allow us to develop novel agents for cancer therapy.”
Cancer is the second most common cause of death in industrialized nations and responsible for about 25% of all deaths. The risk of malignancy increases with age – which means that research into the development and treatment of cancer is of great economic and personal interest in an aging society. CECAD, the Cluster of Excellence at the University of Cologne, is carrying out research into aging and its associated diseases. CECAD’s vision is to develop new treatments for the entire spectrum of age-related diseases. Given this aim, the latest findings from Dr. Lammers and his team are of great import.
Published in: Proc. Natl. Acad. Sci. U. S. A.; on June 29th 2015 (Epub)
de Boor, S.*, Knyphausen, P.*, Kuhlmann, N., Wroblowski, S., Brenig, J., Nolte, H., Krüger, M., and Lammers, M. (2015). Small GTP-binding protein Ran is regulated by posttranslational lysine-acetylation. Proc. Natl. Acad. Sci. U. S. A.] 12(28):E3679-88. doi: 10.1073/pnas.1505995112. Epub 2015 Jun 29.
*(contributed equally to the work)
Dr. Michael Lammers
Tel. +49(0) 221-478-84308/84314
Astrid Bergmeister MBA
Head of PR & Marketing, CECAD
University of Cologne
Phone: +49 (0)221 478 84043
Astrid Bergmeister | idw - Informationsdienst Wissenschaft
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences